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LONG-TERM INCIDENCE OF DRY EYES AND VISUAL ABERRATIONS 
AFTER CORNEAL REFRACTIVE SURGERY  
 
SAMUEL G. HILBERT  
ABSTRACT 
Introduction/Purpose 
 Billions of people world wide suffer from refractive errors requiring glasses, 
contact lenses, or other means of correction to enable them to see better. Many people 
seeking permanent means to correct their vision consider undergoing corneal refractive 
laser surgeries (CRLS), photorefractive keratectomy (PRK), laser-assisted subepithelial 
keratectomy (LASEK), or laser in situ keratomileusis (LASIK). These surgeries have 
been shown to improve vision, but are not without risks for complications intra-
operatively and postoperatively. Few studies have looked at the long-term incidence of 
postoperative complications such as dry eyes and visual aberrations and the associated 
preoperative risk factors. It is the aim of this study to examine the long-term incidence of 
dry eyes and visual aberrations (starbursts, halos, glare) after CRLS, and assess for 
preoperative risk factors associated with the persistence of these symptoms after surgery. 
Methods 
This study consisted of 319 patients identified for undergoing PRK, LASEK, or 
LASIK, at Boston Laser between December 2009 and January 2014. The participants in 
this study completed a novel online questionnaire consisting of questions to assess dry 
eye and visual aberration symptoms, and included questions adapted from the Ocular 
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Surface Disease Index (OSDI). Postoperative dry eye symptoms were measured based on 
the OSDI score and a new dry eye measurement score created for this study’s 
questionnaire. Presence or absence of visual aberration symptoms postoperatively were 
measured based on a score created for this study and derived from the calculation of the 
OSDI score. Additionally, a retrospective chart review was conducted of the 319 
participants’ medical charts to gather and assess for preoperative risk factors related to 
the long-term incidence of both dry eye and visual aberration symptoms. 
Results 
Our data found a significant association (p < 0.05) that suggests a relationship 
between development of long-term dry eye symptoms and the following preoperative 
variables: pupil size, flap thickness, and dry eye risk assessment (including: Zone Quick 
test values ≤ 9.0mm, contact lens use, and dry eyes with and without contact lenses). No 
significant association (p > 0.05) was found between the novel dry eye score and the 
preoperative factors, but it did approach significance with two variables, necessitating 
further investigation: gender and actual ablation. No significance (p >0.05) was found in 
the association between the preoperative dry eye risk assessment and severity of 
postoperative symptoms as gathered using the OSDI score. 
Our data found a significant association (p < 0.05) that suggests an increased risk 
for development of long-term visual aberrations symptoms postoperatively with the 
following preoperative variables: cylindrical manifest refraction, flat K, and greater 
actual flap thickness. As well as identifying two other possible variables that approached 
significance requiring further investigation: steep K and preoperative visual aberrations 
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risk (including: spherical manifest refraction ≥ -6.00, astigmatic manifest refraction ≥ -
2.00, and pupil diameter ≥ 7.0). The data showed a significant association (p < 0.05) 
between postoperative symptom presence and the aforementioned preoperative visual 
aberrations risk. Our data showed no significance (p > 0.05) when comparing the 
difference between mean OSDI, dry eye, and visual aberration scores between 
participants grouped by years since surgery.  
Discussion/Conclusion 
 Our data found a significant relationship between long-term dry eye risk after 
CRLS and preoperative pupil size, flap thickness, and dry eye risk assessment. Similarly 
the data also displayed a significant association between long-term visual aberration risk 
after CRLS and greater preoperative cylindrical manifest refraction, flat K, and flap 
thickness. These findings contribute to the risk factors identified in similar short-term 
follow-up studies, and support the need for increased research into the risk factors and 
long-term incidence of dry eyes and visual aberrations after CRLS. While the data 
showed no significance between participants grouped by years since surgery and reported 
postoperative symptoms, the OSDI mean scores did approach significance (p = 0.088), 
suggesting that further research with a greater survey population is required. 
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INTRODUCTION 
It has been estimated that 670 million people worldwide have visual impairment 
due to uncorrected refractive errors (Naidoo & Jaggernath, 2012). Refractive errors occur 
due to improper focusing of light as it is bent or refracted when it enters the eye through 
the cornea, passes through the lens, and stimulates the retina at the back of the eye. An 
emmetropic, normal eye causes light rays to be focused directly onto the retina allowing 
for optimal distance vision (Chang, 2011). In a hyperopic eye the shorter length of the 
eye causes the light rays to reach a focal point that is at an imaginary point behind the 
retina, which is known as farsightedness (Chang, 2011). Conversely, the myopic eye has 
a longer length than the emmetropic eye causing the light rays to reach a focal point in 
front of the retina, which is known as nearsightedness (Chang, 2011). While these are the 
major classifications of refractive error there are many variants to these errors including 
several categories of astigmatism, which refers to situations when the light entering the 
eye results in multiple focal points (Riordan-Eva, 2011). Refractive errors can also be due 
to the irregularities in corneal curvature (Riordan-Eva, 2011). 
Visual impairment due to refractive errors can be corrected via non-permanent 
methods, such as glasses and contact lenses, and permanent measures, such as 
implantable contact lenses and corneal refractive surgeries. However, there are 
limitations associated with all types of refractive error corrections. Glasses can be 
inconvenient and costly to repair or replace; contact lenses have recurring costs and 
associated health risks such as: corneal infections, corneal abrasions, neovascularization, 
corneal edema, and allergic responses (Cochrane, Toit, & Mesurier, 2010). Due to the 
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daily regimen of care and risks associated with non-permanent methods of correction, it 
is of no surprise that the permanent methods of correction are increasing in popularity, as 
shown by the estimate that around 16 million people worldwide have already undergone 
corneal refractive surgery (Riordan-Eva, 2014). 
 
Corneal Refractive Surgeries 
There are two common techniques for corneal refractive laser surgery (CRLS) 
performed today to correct refractive error: surface ablation and lamellar (Figure 1). Both 
techniques involve the use of an excimer laser, which causes photodecomposition to 
ablate and reshape the cornea to correct for the irregular shape of the eye (Chong, 2011). 
The difference between the two methods is the depth at which the ablation occurs. In the 
surface ablation procedures, laser-assisted subepithelial keratectomy (LASEK) and 
photorefractive keratectomy (PRK), the laser is fired after the thin corneal epithelium is 
displaced, with LASEK, or removed, with PRK (Biswell, 2011; Figure 1). These two 
procedures are similar except that in LASEK the corneal epithelium is replaced after 
ablation, and some studies have suggested that this epithelial replacement can decrease 
pain, decrease corneal haze, and allow for better visual acuity earlier in the recovery 
process as compared to after PRK surgery (Lee et al., 2001; Shah et al. 2001). However, 
other studies have disagreed with this idea, showing no significant differences in these 
factors between LASEK and PRK (O’Doherty et al. 2007). In the lamellar procedure, 
laser in situ keratomileusis (LASIK), the laser is fired after a flap has been created at a 
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specific depth in the corneal epithelium and folded away from the operative part of the 
cornea (Biswell, 2011; Figure 1). 
 
Figure 1. Three common CRLS procedures: PRK, LASEK, and LASIK. Common CRLS 
procedures (PRK, LASEK, and LASIK) and the management of the cornea before laser ablation 
(“LASIK vs LASEK, PRK y epi-LASEK - Operación de Ojos,” n.d.; Biswell, 2011).  
 
Surface ablation and LASIK can be used to treat varying degrees of myopia, 
hyperopia, and astigmatism. According to a report by the American Academy of 
Ophthalmology, depending on the excimer laser used, the FDA has approved surface 
ablation treatments of myopia up to -13.00 diopters (D), astigmatism up to -4.50 D, and 
hyperopia between +0.50 D to +6.00 D (“Refractive Errors & Refractive Surgery PPP - 
2013 - American Academy of Ophthalmology,” n.d.). Additionally, the same report 
indicated that, depending on the excimer laser used, the FDA has approved LASIK 
treatments of myopia up to -14.00 D, astigmatism up to -6.00, and hyperopia between 
+0.50 D to +6.00 D (“Refractive Errors & Refractive Surgery PPP - 2013 - American 
Academy of Ophthalmology,” n.d.). Although the FDA has approved large ranges of 
treatment, studies have shown that a more conservative degree of treatment will lead to 
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more predictable visual outcomes: less than -8.00 D of myopia, less than -5.00 D of 
astigmatism, and less than +4.00 D of hyperopia (O’Keefe & Kirwan, 2010; Sutton, 
Lawless, & Hodge, 2014). 
While the range of refractive errors is an important determinant of whether a 
patient is a good candidate for surgery, many other factors affect the treatment decision. 
The following factors must be evaluated before a patient is approved for CRLS: 
refractive stability (less than 0.50 D of change in the past year), corneal thickness, 
corneal curvature, pupil size, tear production, and medical diagnoses history (Sutton, 
Lawless, & Hodge, 2014). These elements are used to rule out contraindications for 
surgery and determine if a patient is eligible for LASIK or LASEK. As shown in Table 1, 
many of the indications for LASEK instead of LASIK are due to the flap created in 
LASIK and ensuring stable corneas after LASIK. For LASIK, corneal thickness should 
be measured to ensure that it is above 500 µm (normal: 530µm-560µm) and that the 
residual stromal bed after ablation is greater than 250-300 µm (Sutton, Lawless, & 
Hodge, 2014). Corneal thickness less than 500 µm is an indication that a surface ablation 
procedure should be selected to decrease risks associated with thin corneas (O’Keefe & 
Kirwan, 2010). Corneal curvature is assessed to ensure that the steepest and flattest 
corneal lines are within the normal range between 39 D and 47 D, which would aid in 
ruling out patients with keratoconus or irregular corneal topography (Sakimoto, 
Rosenblatt, & Azar, 2006). Additionally, pupil size (for laser optical zone selection), tear 
production (to assess dry eye symptoms), and complete medical diagnosis history should 
be collected to rule out conditions that are contraindications for CRLS, such as: Dry Eye 
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Syndrome (DES), glaucoma, or keratoconus, among others. (Table 2) (Sutton, Lawless, 
& Hodge, 2014).  
Table 1. Indications for LASEK surgery. Reasons that a patient undergoing CRLS would select 
LASEK surgery as opposed to LASIK. Adapted from O’Keefe & Kirwan, 2010. 
Corneal thickness <500µm 
Recurrent corneal erosions 
Post-LASIK flap complications 
Retreatment after LASIK 
Contact sports 
Occupation 
 
Table 2. Contraindications for CRLS. Conditions that could cause a patient to be ineligible to 
undergo CRLS. Adapted from Sutton, Lawless, & Hodge, 2014. 
Unstable Refractions (>0.50 D change in year prior) 
Inadequate central corneal thickness or thin corneas (dependent on required ablation depth) 
Abnormal or irregular corneal topography 
Inadequate tear production, dry eye symptoms, or Dry Eye Syndrome diagnosis 
Significant corneal scarring 
Recurrent corneal erosions (may be more suitable for PRK procedures) 
History of herpes simplex keratitis or herpes zoster ophthalmicus 
Atopic Disease 
Autoimmune Disorders (such as Sjögren’s Syndrome) 
Glaucoma (LASIK procedures, due to the pressure created on the eye during flap creation) 
Pregnancy (due to inability to take pre-/postoperative medications) 
Keratoconus 
Visually significant cataract 
Uncontrolled ocular or systemic disease 
Unrealistic patient expectations 
 
After ruling out contraindications and deciding on a type of treatment, LASIK or 
LASEK, a final factor that must be discussed before surgery is type of ablation: 
traditional ablation or custom (wave-front guided) ablation. Both traditional and custom 
treatments are possible with LASIK and LASEK; however the visual results of each have 
been shown to vary depending on the degree of correction needed (Sakimoto, Rosenblatt, 
& Azar, 2006). While traditional treatments correct vision using the spherical and 
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astigmatic portions of the patient’s dilated and non-dilated (manifest) refractions, custom 
treatments use other measurements specific to each eye to help correct for higher order 
aberrations, which might improve visual results and reduce the likelihood of visual 
aberrations after surgery (Sakimoto, Rosenblatt, & Azar, 2006). However, custom 
treatments aimed at correcting a wider scope of visual symptoms beyond the refractive 
data will inevitably necessitate a larger degree of ablation (Sakimoto, Rosenblatt, & Azar, 
2006). A review by Sakimoto, Rosenblatt, and Azar (2006) analyzed results from 
multiple studies, both independent investigator and FDA studies, showing the differences 
between custom and traditional treatments and between myopia and hyperopia in LASIK, 
LASEK, and PRK procedures (Table 3). This review showed that in myopic treatments 
(0.00 D to -7.00 D) the uncorrected distance visual acuity (sc-Dva) was better than 20/40 
in 96% of patients and 20/20 or better in 72% of patients receiving traditional LASIK 
(Sakimoto, Rosenblatt, & Azar, 2006). The sc-Dva was better than 20/40 in 98% of 
patients and 20/20 or better in 89% of patients receiving custom LASIK (Sakimoto, 
Rosenblatt, & Azar, 2006). Similarly, hyperopic treatments (0.00 D to +6.00) showed 
improvements from 90% to 97% in sc-Dva of better than 20/40 when comparing 
traditional LASIK to custom LASIK, but the percent of patients with sc-Dva of 20/20 or 
better dropped from 63% to 60% when comparing traditional LASIK to custom LASIK 
for hyperopia (Sakimoto, Rosenblatt, & Azar, 2006). Additionally, the data gathered in 
the review showed similar results when comparing both PRK and LASEK to LASIK for 
myopia and hyperopia (Table 3); however, high myopic LASIK patients showed a 
reduction in the percentage of patient who attained sc-Dva of 20/20 or better, which 
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supported previously mentioned suggestions regarding less predictable visual outcomes 
with higher degrees of treatment (Sakimoto, Rosenblatt, & Azar, 2006). 
Table 3. Comparison of visual outcomes of traditional PRK, LASEK, and LASIK for myopia 
and hyperopia. The percentage of patients with sc-Dva at better than 20/40 and equal to or 
better than 20/20 for myopic and hyperopic LASIK, LASEK, and PRK procedures. Adapted from 
Sakimoto, Rosenblatt, & Azar, 2006. 
 Myopia Hyperopia 
PRK LASEK LASIK – 
Traditional 
LASIK – 
Traditional 
PRK LASEK LASIK – 
Traditional 
Visual Range -1 to -
13.0 D 
-1 to -
12.5 D 
0 to -7 D -7 to -12 D +1 to 
+5 D 
+2 to 
+5 D 
0 to +6 D 
sc-Dva >20/40 94.3% 94.5% 96% 89% 87.1% 90.7%  90% 
sc-Dva ≥20/20 61.1% 73.9% 72% 48% 75.2% 73.1% 63% 
 
While the visual results have been shown to be similar between LASIK and 
LASEK procedures, the differences between treatments can cause variance in the major 
complications that can arise after surgery. As shown in Table 4, there are a number of 
complications specifically related to flap creation during LASIK, that are avoided by 
surface ablation techniques; however, the chance of these complications occurring is 
usually small and the continued popularity of LASIK procedures over surface ablation 
can most likely be attributed to the often faster and less painful visual recovery with less 
chance of postoperative corneal haze (Shah & Melki, 2014). Furthermore, beyond flap-
associated complications there are similar complications that can occur with both LASIK 
and surface ablation techniques, albeit to varying degrees depending on type of procedure 
(Table 4). For example, it has been indicated that regression after surgery can occur with 
both types of treatments, but higher-order visual aberrations (halos, glare, rainbow glare, 
starbursts; Figure 2) and risk of corneal ectasia are higher after LASIK surgery as 
compared to LASEK surgery (O’Keefe & Kirwan, 2010). Postoperative haze, more 
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common in surface ablation techniques, can be reduced with the use of Mitomycin-C 
(MMC) during surgery (Hashemi et al. 2004). While there are varying frequencies of 
each type of complication listed in Table 4, dry eyes and visual aberrations, such as glare, 
are of the most common complaints following CRLS (Jabbur, Sakatani, & O’Brien, 
2004). 
Table 4. Complications of LASEK and LASIK surgeries. Intra-operative and Postoperative 
complications associated with LASIK flap creation and some common postoperative 
complications after LASIK and LASEK surgeries. (Jabbur, Sakatani, & O’Brien, 2004; Sakimoto, 
Rosenblatt, & Azar, 2006; Schallhorn, Amesbury, & Tanzer, 2006; O’Keefe & Kirwan, 2010; Na et 
al., 2012; Shah & Melki, 2014)  
 LASIK Reported 
Frequency 
(LASIK) 
LASEK Reported 
Frequency 
(LASEK) 
Intra-operative 
flap-related 
complications 
(from primary 
treatments with 
femtosecond 
laser) 
Loss of 
suction/Incomplete flaps 
4.4%   
Thin, buttonholed flaps 
with vertical gas 
breakthrough 
0.33%   
Flap tears 0.4% – 2.2%   
Anterior chamber gas 
bubbles and opaque 
bubble layers 
0.3%   
Epithelial defect 0.6%   
Bleeding at edge of flap Unreported   
Bleeding due to suction 68.9%   
Flap interface debris 1.9% - 100%   
Postoperative 
flap-related 
complications 
Dislocated flaps 1.1%   
Striae and folds 1.6% – 15%   
Epithelial ingrowth 0.14% – 9.1%   
Diffuse lamellar keratitis 0.2% – 10.6%   
Non-flap-
specific 
complications 
Keratitis/infection  0.03% Infection = LASIK 
Dry eye 8% – 48% Dry eyes < LASIK 
Haze 0.50% – 22.6% Haze 6.6% –63.6% 
Higher-order visual 
aberrations 
5.8% – 26.7% Higher-order 
visual 
aberrations 
12% – 41% 
Regression = LASEK after 
2 years 
Regression 2.1% 
Ectasia 0.2% Ectasia < LASIK 
Transient light-
sensitivity syndrome 
0.4%   
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Dry Eyes 
Dry eyes symptoms after LASIK have been reported by up to 50% of patients in 
some studies (Ambrósio, Tervo, & Wilson, 2008). Dry eye symptoms are highly varied in 
each individual and can include: foreign body sensation, itching, irritation, tearing, 
soreness, redness, blurry/fluctuating vision, photophobia, contact lens intolerance, 
symptoms that are ameliorated with artificial tear usage, and symptoms that vary 
depending on location or time of day (“Dry Eye Syndrome PPP - 2013 - American 
Academy of Ophthalmology,” n.d.). Assessing for dry eye risk before surgery should be 
done by ocular and systemic medical history evaluation, visual acuity measurement, slit-
lamp examination, as well as diagnostic tests such as: tear breakup time test (TBUT) 
(evaluates tear film stability), rose bengal, fluorescein dye or other ocular surface staining 
(evaluates ocular surface damage), and Schirmer test (evaluates aqueous tear flow) 
(Perry, 2008). Risk factors for dry eyes include: old age, female sex (greater risk after 
menopause), autoimmune disorder (e.g. Sjögren’s Syndrome), or use of medications that 
can promote eye dryness (e.g. antidepressants and antihistamines) (“Dry Eye Syndrome 
PPP - 2013 - American Academy of Ophthalmology,” n.d.). Additionally, assessing for 
dry eye risk before surgery is important because CRLS can worsen symptoms in 
preexisting dry eye conditions (Ambrósio, Tervo, & Wilson, 2008). It has been suggested 
that denervation of sensory neurons at the cornea during LASIK can reduce the eye’s 
blink reflex and tear production resulting in the dry eye symptoms commonly reported 
after CRLS (Battat et al. 2001). While it has been stated that the denervation of sensory 
neurons is the most likely cause of dry eye symptoms, other theories include greater tear 
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evaporation and damage to “goblet cells and microvilli at the limbus” (Shah & Melki, 
2014). Furthermore, studies have shown that LASIK surgery alters the results of many 
diagnostic tests used in evaluating dry eye symptoms, such that after LASIK there is a 
decrease in Schirmer test value, decreased TBUT, and decreased basal tear secretion (Yu 
et al. 2000). Studies have similarly shown decreases in Schirmer test and TBUT values 
following surface ablation procedures, PRK and LASEK (Horwath-Winter et al. 2004). 
Alternatively, it has been reported that there is a decrease in the subjective and objective 
presentation of dry eyes after LASEK and PRK as compared to LASIK with 
greater/quicker return to baseline, which could be explained by the idea that absence of 
flap creation allows for less damage to the corneal sensory neurons (Herrmann et al., 
2005).  
It has been demonstrated that dry eye risk after LASIK is specifically related to 
degree of correction for myopia, thus the higher degree of correction means a larger laser 
ablation depth and increased risk (De Paiva et al., 2006). However, a more recent study 
indicated that, for both LASIK and surface ablation procedures, there are no correlations 
between the subjective dry eye symptoms and the patients’ age, ablation depth, and flap 
thickness (Murakami & Manche, 2012). While current literature is divided, in part due to 
small sample size, dry eyes after CRLS have also been correlated with contact lens use, 
preexisting dry eye conditions, hyperopic treatments, and Asian race (Raoof & Pineda, 
2014).  Additionally, studies have shown varying results regarding the length of time dry 
eye symptoms can persist after surgery, often approximately 20% of patients still 
experience symptoms at six months or more (De Paiva et al., 2006; Shoja & Besharati, 
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2007; Raoof & Pineda, 2014).  A recent review by Raoof and Pineda (2014) highlighted a 
dry eye treatment progression, using some of the commonly prescribed treatments, 
beginning with artificial tears and, as the severity of symptoms increases or persists, to 
treat using punctal plugs, topical cyclosporine, autologous serum tears, and for the most 
severe cases consideration of scleral lenses or prosthetic replacement of the ocular 
surface.  
 
Visual Aberrations 
As discussed previously, visual aberrations are a common complication after 
CRLS. Examples of possible visual disturbances after CRLS, as seen in figure 2, show 
halos, starbursts, and glare on the left as some of the more common complaints after 
surgery. However, these symptoms are not specific to CRLS surgery, those who wear 
contact lenses and glasses have also reported these disturbances (Schallhorn et al. 2009). 
One additional symptom (not shown in figure 2), rainbow glare – glare with distinct 
bands of color, has been shown to be specific to femtosecond laser created flaps, as 
opposed to microkeratome created flaps, and presents within 3 months after surgery 
(Farjo et al., 2013). It has been reported that this symptom is likely due to the pattern 
made by the laser during flap creation and that no correlation has been shown between 
risk for rainbow glare and age, gender, or level of correction (Farjo et al., 2013). 
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Figure 2. Examples of visual aberrations. Possible visual abnormalities that can be seen 
following CRLS. Adapted from (Boston Laser, 2014). 
 
There have been varying results for the percentages of patients reporting the more 
common visual aberrations after surgery and the risk factors associated with them, 
including pupil size, arguably the most debated (Myung, Schallhorn, & Manche, 2013). 
In a 2003 study the results of a questionnaire mailed to patients who had surgery at least 
6 months prior to answering the survey showed that, of the patients that did not report 
any symptoms before LASIK, 30.0% experienced halos, 24.5% experienced starbursts, 
and 27.2% experienced glare after surgery (Bailey et al. 2003). While that study did not 
show any correlation between the visual complications and pupil size or corneal 
asphericity, it did show a relation between glare and level of myopia, “preoperative 
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minimum corneal curvature and starbursts, and preoperative minimum and maximum 
corneal curvature and halos” (Bailey et al. 2003). Alternatively, another study reported 
that the results of a questionnaire given 6 months after surgery showed no correlations 
between level of correction and glare (Bamashmus et al. 2015). Risk factors for 
experiencing at least one of the three common visual aberrations include: enhancement 
surgeries, younger age, and increased depth of ablation (Bailey et al. 2003). Another risk 
factor for these visual aberrations could be the use of wave-front guided (custom) 
treatments versus the traditional treatments because, as mentioned previously, the custom 
treatments correct for higher-order aberrations instead of just spherical and astigmatic 
correction like in traditional treatments. There are decreased reports of glare after LASIK 
surgery using custom treatments as opposed to traditional surgery (Lee et al. 2006). One 
study analyzing wave-front data after LASIK surgery has shown that for the scotopic 
(dim-light) pupil size there is an association of both the spherical and total higher order 
aberration with both glare and starbursts, and the spherical aberration with halos (Chalita 
et al. 2004). Additionally it was shown that there was a positive correlation between 
starbursts and pupil diameter (Chalita et al. 2004). 
 There are also varying reports on the incidences of visual aberrations after CRLS. 
A study comparing the incidences of visual aberrations using a questionnaire before 
surgery and at 1, 3, 6, and 12 months after surgery showed no difference in the levels of 
glare or halo symptoms between LASIK and PRK eyes after one month, and for both 
types of procedures the severity of symptoms returned to near preoperative levels within 
one month of treatment (Manche & Haw, 2011). Another study also showed no 
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statistically significant difference between LASIK or PRK treatments in glare or halos in 
a six month follow-up questionnaire, but using the combination of glare and halo 
symptom scores showed that patients who underwent surface ablation treatment had more 
severe visual aberration symptoms after surgery than did LASIK patients (Hersh, 
Steinert, & Brint, 2000). Alternatively, a 1999 study using a questionnaire to assess 
incidence of visual aberrations two years after surgery showed that patients reported 
symptoms in 21% of eyes that received LASIK, where as symptoms were reported in 
35% of eyes that received PRK treatment (El-Maghraby et al. 1999). 
 
Study Rationale 
There has been considerable debate, with study data supporting both sides, 
concerning those factors that put patients at increased risk for dry eyes and visual 
aberrations after CRLS; however, many studies fail to assess the persistence of symptoms 
beyond the one-year follow-up period after surgery. Additionally, those studies tend to 
have small sample sizes often considering the number of individual eyes rather than 
patients. Of those studies that consider long-term implications of refractive surgery, many 
do not mention or appear to assess dry eye symptoms or visual aberrations, or exclude 
candidates that report dry eye symptoms preoperatively (Autrata & Rehurek, 2003; Alió 
et al., 2008). A 4 year follow-up study after LASIK reports that for 22 PRK and 18 
LASIK eyes there is a significant improvement in best corrected visual acuity (BCVA) in 
LASIK as compared to PRK from 6 months through 2 years, but this advantage was not 
maintained longer than 2 years after surgery due to myopic shift, and does not mention 
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visual aberrations or dry eye complications (Miyai et al., 2008). In a study examining 120 
patients from one of the first PRK clinical trials at a 12 year follow-up, there were no 
significant changes reported from the 6 year follow-up of the same group, and much of 
the focus was on BCVA (Rajan et al. 2004). This study was one of few long-term studies 
that assessed visual aberrations and dry eyes. The data indicated that 12% of patients 
experienced night vision complications, including halos, at both 6 and 12-year follow-
ups; furthermore, patients who had received more than 4 D of myopic correction 
experienced more severe symptoms than those that had underwent milder corrections, but 
none of the symptoms worsened and all patients claimed improvements over the 12 year 
follow-up period (Rajan et al. 2004). Additionally the study indicated that 3-6% of 
patients showed signs that could by related to dry eyes upon slit lamp evaluation (Rajan 
et al. 2004). 
From this literature review it is evident that, while many studies report that 
objective measurements and subjective reports of dry eyes return to baseline within one 
year, few studies have evaluated dry eye symptoms and visual aberrations past that 
follow-up period after CRLS (Murakami & Manche, 2012). Our goal is to address this 
gap in literature and investigate the long-term incidence of these symptoms in CRLS 
patients and attempt to identify factors correlated with their persistence, if any. 
Additionally, an increased risk of regression has been correlated with persistent dry eyes 
after LASIK surgery, showing the importance of elucidating the risks for chronic dry eye 
after CRLS (Schallhorn, Amesbury, & Tanzer, 2006). Therefore, our study will also aim 
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to provide further insight into the risks associated with persistent dry eye and visual 
aberrations after CRLS. 	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SPECIFIC AIMS 
The main objective of our study is to examine the long-term incidence of dry eyes 
and visual aberrations after CRLS, specifically:  
1) Our study will select candidates that underwent CRLS at Boston Laser and 
whose date of surgery was at least one year prior to February 2015. Participants 
will be selected based on their affirmative response and consent to an electronic 
questionnaire e-mailed to all candidates. 
2) Subjective data from the electronic questionnaire completed by participants 
will be examined. Pre-surgery data relating to risk for dry eyes and visual 
aberrations will be collected and matched with participant survey responses. 
3) Statistical analysis between pre-surgery risk factors, time since surgery, and 
questionnaire responses will be determined.  
We hope to show:  
• A decrease in the persistence of dry eye symptoms and visual aberrations over 
time from 1-6 years post-surgery.  
• A correlation between those patients that are still experiencing dry eye symptoms 
longitudinally after surgery through subjective responses on the study survey, and 
those that exhibited risk for dry eyes before surgery of: subjective reports of dry 
eyes with and without contact lenses before surgery, DES diagnosis before 
surgery, and Zone Quick test values less than or equal to 9mm before surgery.  
• A correlation between patients that are still experiencing visual aberrations 
longitudinally after surgery and patients who before surgery had risk factors of: 
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pupil size greater than or equal to 7mm, spherical manifest refraction greater than 
or equal to 6.0, astigmatism greater than or equal to 2 
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METHODS 
Study Design Overview 
The design of our study consisted of three parts. The first part was a retrospective 
analysis of qualifying patient data. Data relating to the patients’ surgery and those risk 
factors associated with dry eyes and visual aberrations were reviewed to determine 
eligibility from patient electronic medical records at Boston Laser. The second part 
entailed e-mailing an invitation to complete an online survey (Appendix A) to all 
qualifying patients who had LASIK, LASEK, or PRK surgery at Boston Laser during the 
period between December 2008 and January 2014. The survey consisted of 20 questions, 
and required approximately 3-5 minutes to complete. After the survey results were 
collected, the medical records of consenting participants were reviewed and the medical 
record data was associated with the survey results; then the study data was anonymized to 
protect patient information. The final portion consisted of a statistical analysis of the data 
from the survey results and the existing electronic medical record information to 
determine if there is any correlation between the pre-surgery risk factors and persistence 
of visual aberrations and dry eye symptoms after surgery. 
 
Demographics / Patient Recruitment and Selection 
The participants in this study were selected from a group of 2926 patients who 
were identified because their medical records indicated that they underwent CRLS with 
Dr. Samir Melki at Boston Laser between December 2008 and January 2014 and they 
met the inclusion and exclusion criteria for the study.  
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Participants included in the study also fit the following criteria: have an active e-
mail address linked to their medical record in the Boston Laser electronic medical 
records, read and virtually agreed to the consent form included as the first page of the 
electronic questionnaire (Appendix A), and completed questions on the survey.  Potential 
participants were excluded from the study if participant: failed to meet the inclusion 
criteria, underwent another corneal surgery after the original CRLS procedure, had a 
medical record that contained an incorrect, suspended, or non-existent e-mail address, or 
did not agree or failed to agree to the consent form. Patients were not excluded from the 
study on basis of gender, age, racial, or ethnic characteristics.  
Electronic medical charts were reviewed of those 319 participants who consented 
to the study. During this retrospective review, demographic information, clinical data 
pertaining to each participant’s specific CRLS, and known risk factors for dry eyes and 
visual aberrations were collected. Pre-surgery clinical data retrieved during the chart 
review included: contact lens wear history, glasses wear history, previous eye diagnoses, 
ocular medication history, manifest and cycloplegic refraction, BCVA, intraocular 
pressure (IOP) measurements, pupil diameter, Zone Quick measurement, keratometry 
(measurement of the radius of corneal curvature), and pachymetry (measurement of 
corneal thickness). Surgery specific data retrieved during the chart review included: 
optical zone size, actual ablation, target flap, actual flap thickness, spherical correction, 
target prescription, preablation bed (actual remaining bed underneath the flap when the 
flap is lifted), actual remaining bed (residual bed = pre-ablation bed – actual ablation), 
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MMC application, 1% cyclopentolate given after surgery, contact lens placement after 
surgery, and any complications with the flap or excimer laser during surgery.  
 
Questionnaire 
Qualifying participants were sent an e-mail with a link to the online questionnaire 
inviting them to participate in this study. The e-mail was sent confidentially using 
Constant Contact’s e-mail service, such that each participant was not able to access the 
contact information of other participants. The e-mail was sent once and then resent six 
days later to all patients that had not yet completed the questionnaire. 
The questionnaire used in this study contained twenty questions on six pages and 
was made using SurveyMonkey.com. The questionnaire was available to participants 
throughout the study duration, and, if a single participant submitted a questionnaire more 
than one time, the most recent complete submission was used. The first page of the study 
contained the consent form, detailing the participant’s role and liabilities of participating 
in the study, and the first question asking the participant to acknowledge that they had 
read, understood, and agreed to the study terms. If a participant selected “yes”, then they 
were directed to the second question, which began the survey; however, if the participant 
selected “no” then they were directed to a disqualification page and not allowed to 
participate in the study. 
 Questions six through eight of our questionnaire were adapted from the Ocular 
Surface Disease Index Questionnaire (OSDI), which has been validated for assessing dry 
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eye symptoms (Schiffman et al. 2000). Question sixteen was adapted from a study by 
Schallhorn et al. (2003) to be used as an assessment tool for evaluating visual aberrations. 
 
Dry Eye and Visual Aberration Score Calculation 
For this study we have developed new scoring methods for dry eyes and a visual 
aberration scoring method specific to the study’s questionnaire. Both the dry eye score 
and visual aberration score were modeled after the OSDI Score calculation: total number 
of points from each question divided by the total number of questions answered and then 
multiplied by a modifier constant that enables the OSDI score to have a minimum of 0 
and maximum of 100.  
 The Dry Eye Score created for this study incorporates the point values of the 
included OSDI questions (Questions 6-8, Appendix A) into the total point calculation. 
The total point range for the OSDI questions was 0-48. In questions 10, 12, 13, and 14, a 
response of “Yes” was considered 1 point, and a response of “No” was considered 0 
points. The total point range for questions 10, 12, 13, and 14 for each question was 0-1. 
In question 9, a response of “None” was considered 0 points, and any other response 
besides none (i.e. “Artificial Tears”, “Gel/Ointment Tears”, “Restasis”, “Other”, “Punctal 
Plugs”) was considered 1 point for each column that did not say none. Total point range 
for question 9 was 0-3. In question 11, a response of “I did not use this medication to 
treat dry eye symptoms in the last week” was considered 0 points, a response of 
“Occasionally (not everyday)” was considered 1 point, a response of “Once a day” was 
considered 2 points, and a response of  “Three or more times a day” was considered 3 
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points. The total point range for question 11 was 0-12. In question 15, a response of “I am 
not experiencing dry eyes” was considered 0 points, a response of “No” was considered 1 
point (because it indicated although they were experiencing dry eyes that it was not worse 
than it was prior to surgery), and a response of “Yes” was considered 2 points. The total 
point range for question 15 was 0-2. The points from all questions were summed into a 
total dry eye points value, which had a maximum value of 69 points. There were 24 total 
responses possible for the dry eye questions in this survey, 12 from the OSDI questions 
and 12 from questions 9-15. If a participant failed to answer a question or selected N/A, 
that question was not counted as part of the score for total questions answered. The final 
dry eyes score was calculated using the following formula: total dry eye points multiplied 
by 34.7827, and then divided by total dry eye questions answered. The 34.7827 constant 
allowed for the score to have a minimum of 0, maximum of 100, and to be significant to 
2 decimal places. 
 The visual aberration score was calculated in a similar manner as the dry eyes 
score. In question 16 the total point range was 0-28. In questions 17 and 18, a response of 
“Yes” was considered 1 point, and a response of “No” was considered 0 points. Total 
point range for questions 17 and 18 was 0-1 for each question. In question 20, a response 
of “I am not experiencing halos, starbursts, or glare” was considered 0 points, a response 
of “No” was considered 1 point (because it indicated that although they were 
experiencing symptoms they were not worse than they were prior to surgery), and a 
response of “Yes” was considered 2 points. The total point range for question 20 was 0-2. 
The points from all questions were summed into a visual aberrations points total value, 
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which had a maximum value of 32 points. There were 10 total responses possible for the 
visual aberrations questions in this survey. If a participant failed to answer a question or 
selected N/A that question was not counted as part of the score for total questions 
answered. The final visual aberrations score was calculated using the following formula: 
total visual aberrations points multiplied by 31.25, and then divided by the total visual 
aberrations questions answered. The 31.25 constant allowed for the score to have a 
minimum of 0, maximum of 100, and to be significant to 2 decimal places. 
 
Clinical CRLS Consultation Procedures 
 Each participant who had CRLS with Boston Laser went through the following 
practice standard consultation procedure before being scheduled for surgery. After 
information regarding referral, co-management, and participant’s profession is gathered, 
the consultation begins by assessing glasses and contact lens wear history. Participants 
are asked whether they wear glasses and/or contact lenses and what percent of time on 
average is spent wearing their glasses, assuming that any non-glasses time would be with 
contact lenses or no correction. Additionally, if participants wear contact lenses, are 
asked first if they experience dry eyes with contact lenses and then if they experience dry 
eyes without contact lenses. Participants were questioned regarding their medical history, 
specifically if they have had any previous refractive surgeries, as well as ocular and 
systemic diagnostic history, allergies, and current medications. 
 The objective portion of the consultation begins by recording each participant’s 
eye dominance, uncorrected distance and near vision (sc-Dva, sc-Nva), and distance 
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vision with present correction (cc-Dva) checked with glasses instead of contact lenses if 
possible. The current glasses prescription is recorded be performing lensometry using the 
Nidek LM-1200 Auto Lensometer (NIDEK Inc., Freemont, California).  
Using either the Abbott Medical Optics WaveScan WaveFront System (Abbot 
Medical Optics Inc., Santa Ana, California) or Nidek TONOREF II (NIDEK Inc., 
Freemont, California), keratometry is performed and an objective refraction measurement 
is obtained. Keratometry data included: the flattest corneal curvature measurement (flat 
K) and steepest corneal curvature measurement (steep K). The objective refraction is next 
used as a basis for determining the participant’s manifest refraction and recording the 
BCVA. Pachymetry information, such as the central and thinnest corneal thicknesses, and 
corneal topography images are gathered using the Ziemer Ophthalmology Galilei G4 
(Ziemer USA, Inc., Alton, Illinois), Zeiss Atlas Topographer (Carl Zeiss Meditex, Inc., 
Dublin, California), or Oculus Pentacam (OCULUS Inc., Arlington, Washington).  
An objective dry eye test is performed using the Oasis Medical Zone Quick 
(Oasis Medical Inc., San Dimas, California) phenol red thread tear test: one Zone Quick 
thread is hung for fifteen seconds from the participant’s lower eyelid at a distance equal 
to one-third of the eye width from the temporal corners of each eye. The tear production 
is determined by measuring the length of string that turned from the original color yellow 
to red using the scale (mm) on the pack of the sterile packaging.  
Pupil size (mm) is measured using the Oasis Medical Colvard Pupillometer (Oasis 
Medical Inc., San Dimas, California) in dim lighting with participants covering the 
opposite eye with the palm of their hand. The lighting is standardized so that 
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measurements are taken with the exam room door closed, all interior lights, including 
computer monitors, are turned off, and the shades of any windows are drawn closed. 
Technicians are instructed to measure the pupil within 0.5mm using the built-in scale, 
while the participant stares at the infrared light inside the pupillometer.  
 Participant IOP is measured via a non-contact method with the Nidek TONOREF 
II (NIDEK Inc., Freemont, California) or with the Reichert Technologies Tono-Pen 
(AMETEK Inc., Depew, NY) after administering 0.5% proparacaine hydrochloride 
ophthalmic solution. After checking IOP, participants’ eyes are dilated with 1% 
tropicamide and 2.5% phenylephrine solution. 
 After full dilation is achieved a cycloplegic refraction as well as fundus and slit-
lamp examination are performed. The treating surgeon discusses the procedure’s benefits 
alternatives and risks after reviewing all the data gathered. A plan is then proposed in 
case the patient is deemed a candidate for surgery. 
 
Surgical Technique – LASIK 
 The LASIK surgical procedure at Boston Laser begins with flap creation in the 
operative eye(s) using a femtosecond laser: the Abbott Medical Optics Intralase FS Laser 
(Abbot Medical Optics Inc., Santa Ana, California). During flap creation the lasers were 
set to aim for a 9mm flap diameter; however, with the Intralase FS Laser there is some 
variation due to centration (centering of the flap on the pupil), but surgeries were not 
performed at less than 8.8mm. Theoretical flap depth with the Intralase FS Laser for most 
patients was between 90 and 100 microns. All flaps created had superior hinge-position. 
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 After flap creation the patient bed moves under the Abbott Medical Optics Star S4 
IR Excimer Laser (Abbot Medical Optics Inc., Santa Ana, California) microscope. The 
participant’s upper eyelid of the operative eye is draped with a tegaderm and the eye is 
held open with a speculum. Next, the flap edge on the operative eye is marked with a 
McKesson Regular Tip Latex-Free Sterile Marker for flap repositioning purposes at the 
end of surgery. The eye is then washed with saline and dried with a LASIK PVA Spear 
(Beaver Visitec International Inc., Waltham, MA). Pachymetry is taken before and after 
the flap lift using external ultrasound pachymetry because the Star S4 IR Excimer Laser 
does not have a built-in pachymeter. After the flap is lifted, last minute centration is 
performed and the excimer laser is fired. During firing, the laser uses a pupil-tracking 
system, and uses Iris Registration to coordinate between the WaveScan measurement and 
the intra-operative laser parameters to ensure that the eye axis remains constant (is treated 
on the same plane). The flap is repositioned using Balance Saline Solution in a 25-gauge 
Yaghouti cannula with 33cc syringe. After repositioning and correct flap alignment using 
the ink mark made before lifting, the eye is rinsed with saline and dried with PVA Spear. 
Three intraoperative drops are then applied: a steroid, prednisolone [1.0%], a nonsteroidal 
anti-inflammatory drug (NSAID), either nepafenac [0.1%] or ketorolac [0.45%], and an 
antibiotic, any fourth generation fluoroquinolone such as Moxeza [0.5%]. After surgery it 
is the practice policy for participants to sit with eyes closed for thirty minutes followed 
by a flap check, and then scheduled for a one-day postoperative follow-up examination. 
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Surgical Technique – LASEK/PRK 
 The LASEK/PRK surgical procedure at Boston Laser begins with the patient bed 
under the microscope of the Abbott Medical Optics Star S4 IR Excimer Laser. The 
participant’s upper eyelid of the operative eye is draped with a tegaderm and the eye is 
held open with a speculum. The edge of a 9mm LASEK trephine is coated using the 
McKesson Regular Tip Latex-Free Sterile Marker to mark the area the treatment zone 
and for epithelium replacement after ablation. The LASEK trephine is placed on the eye 
and filled with a 20% ethanol solution, made with 2cc medical grade 100% ethanol and 
8cc sterile water using a 23-gauge cannula. The alcohol is left in the trephine for 40 
seconds to loosen the epithelium before it is absorbed using a PVA Spear and the eye is 
washed with saline solution. For LASEK surgical procedures the epithelium is displaced 
outside the ablation zone using a LASEK spatula, and for PRK the epithelium is removed 
using a LASEK spatula and PVA Spear. Following epithelial displacement/removal the 
laser is fired and then a corneal light shield saturated with MMC [0.2mg/ml] is applied 
for a variable time depending on ablation depth (Table 5). After the MMC treatment is 
completed the eye is rinsed with cold saline solution, and for LASEK surgeries the 
epithelium is repositioned using the LASEK spatula. Hydro-silicone bandage contact 
lenses are placed on the operative eye at the end of surgery. Three intraoperative drops 
are then applied: a steroid, prednisolone [1.0%], a NSAID, either nepafenac [0.1%] or 
ketorolac [0.45%], and an antibiotic, any fourth generation fluoroquinolone such as 
Moxeza [0.5%]. Finally, the pupil of the operative eye(s) is dilated using 1% 
cyclopentolate.   
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Table 5. MMC application time. The Boston Laser practice standard for MMC application time 
based on ablation depth during LASEK or PRK surgeries. 
Ablation Depth (µm) MMC Time (seconds) 
< 70 20 
70-90 30 
91-110 40 
111-130 50 
> 130 60 
 
Statistical Analysis 
Microsoft Excel software version 14.0.0 (Microsoft Corporation, Redmond, WA) 
and SPSS software version 13.0 (SPSS, Inc., Chicago, IL) were used for statistical 
analysis. A paired t test was used to compare continuous variables and Logistic 
regression was used to search for risk factors. Chi square test was used to compare 
qualitative proportions and ANOVA test was used to compare quantitative means. 
Probabilities of less than 5% were considered significant (p < 0.05), and probabilities less 
than 1% were considered to be highly significant (p < 0.01). 
 
IRB approval 
 This study, its protocol, and the participant informed consent form was approved 
as an expedited review study by Sterling IRB (Sterling Institutional Review Board, 
Atlanta, Georgia) on February 6, 2015 under IRB identification number 4997-001 
(Appendix B). Additionally, Sterling IRB approved a waiver of documentation of 
informed consent for this study on that same date (Appendix B).  
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RESULTS 
Survey Invitation Response 
There were 2926 patients who were identified because their medical records 
indicated that they underwent CRLS with Dr. Samir Melki at Boston Laser between 
December 2008 and January 2014, and met inclusion and exclusion criteria. Of the 2926 
patients, CRLS was performed on both eyes of 2755 patients (94.2%), only the right eye 
of 103 patients (3.5%), and on the left eye of 68 patients (2.3%). From the electronic 
medical records of those 2,926 patients, 2,515 patients (86%) had e-mail addresses on 
file, some with multiple addresses.  
In the first round of survey invitation e-mails, 2,644 e-mails were sent and 448 
(16.9%) of those bounced because the e-mail address was incorrect, suspended, or non-
existent. Additionally, 8 of those addresses opted-out of receiving further e-mails and 1 
reported it as spam. Therefore, a total of 2,196 e-mails (83.1%) were successfully sent. 
Of these 2,196 e-mails, Constant Contact was able to track recipient interaction with the 
survey invitation e-mail and showed that 1,388 recipients (63.2%) opened the e-mail and 
358 recipients  (16.3%) clicked the survey link. 
 One week later, a second round of e-mails was sent to all those patients who had 
not yet responded to the survey. 2,324 e-mails were sent, 383 (16.5%) of those bounced, 
and 7 recipients opted-out of receiving further e-mails. Therefore, a total of 1,941 e-mails 
(83.5%) were successfully sent. Of these 1,941 e-mails, Constant Contact reported that 
804 recipients (41.4%) opened the e-mail and 152 (7.8%) clicked the survey link. 
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 Therefore, of the 2,926 patients that were eligible for this study, 510 e-mail 
recipients (17.4%) clicked the survey link and 380 participants (13.0 %) entered data in 
the survey; however only 319 (10.9%) participants answered questions pertaining to 
CRLS (Figure 3). 
 
Figure 3. Flow diagram of survey responders who were included in the study analysis. 
Flow diagram showing the derivation of the 319 participants included in this study from the 
original 380 responses to the survey, including disqualification due to: lack of consent, incomplete 
identification page, missing CRLS question responses, exclusion criteria discovered within survey 
responses. 
 
Preoperative Demographics 
The majority of included participants (n=303; 95.0%), underwent CRLS in both 
eyes, while 9 participants (2.8%) received treatment in only the right eye and 7 
participants (2.2%) received treatment in only the left eye. The 319 participants that 
underwent CRLS accounted for 622 treated eyes, which included: 94 eyes receiving 
LASEK with MMC (82 custom treatments, 12 traditional treatments), 44 eyes receiving 
380 Survey Responses 
11 not 
consenting 
to survey 
Disqualified 
369 Consenting to survey 
42 did not complete 
identification page 
Disqualified 
327 
completed 
identification 
page 
6 did not 
answer CRLS 
questions 
Disqualified 
2 participants 
disqualified 
due to 
exclusion 
criteria 
Disqualified 
319 
participants 
answered 
CRLS 
questions 
Included 
in study 
	  32 
LASEK w/o MMC (35 custom treatments, 9 traditional treatments), and 484 eyes 
receiving LASIK (401 custom treatments, and 83 traditional treatments).  
There were 31 hyperopic eyes (5.0%), 585 myopic eyes (94.0%), and 6 planar 
eyes (1.0%). Of the myopic eyes, 94 (16.1%) had a spherical manifest refraction greater 
than or equal to -6.0, which was considered a risk factor for visual aberrations. 
Additionally, 42 eyes (6.8%) had a cylindrical manifest refraction greater than or equal to 
-2.0; astigmatism greater than -2.0 was considered a risk factor for visual aberrations.  
The preoperative BCVA of the majority of participants (97.0%) was 20/20 or 
better, with only 3.0% of participants recorded with a manifest BCVA of worse than 
20/20, the worst being 20/30. 
171 males (53.6%) and 148 females (46.4%) participated in this study (Table 6). 
Participant ages ranged from 20 years old to 70 years old with a mean of 37.88 ± 9.91. 
The average time since surgery was 2.5 ±1.24 years (range: 1-6 years). Mean pupil size, 
measured preoperatively, was 5.75 ± 0.89 mm, and equal to or larger than 7 mm was 
selected to indicate risk for visual aberrations. Schimer test value less than or equal to 9 
mm was selected to indicate risk for dry eye symptoms and the mean preoperative test 
value was 20.54 ± 6.76 mm. 
 
 
 
 
 
	  33 
Table 6. Preoperative demographic factors and postoperative correlations. The means and 
standard deviations of relevant preoperative participant data and correlations from ANOVA 
logistic regression to postoperative survey scores: OSDI, dry eye, and visual aberration. (Not 
shown: Gender was correlated with Dry Eye Score at p = 0.071) (Bold text: significant values) 
Preoperative Factor Mean Standard 
Deviation 
(±) 
OSDI Score 
Significance 
(p) 
Dry Eye 
Score 
Significance 
(p) 
Halo Score 
Significance 
(p) 
Age (years) 37.88 9.905 0.473 0.632 0.648 
Time after surgery (years) 2.50 1.244 0.503 0.510 0.790 
Manifest Spherical 
Refraction (D) 
-3.41 2.346 0.324 0.158 0.303 
Manifest Astigmatic 
Refraction (D) 
-0.92 0.677 0.841 0.207 0.025 
Pupil Size (mm) 5.75 0.892 0.036 0.385 0.438 
Zone Quick Test (mm) 20.54 6.762 0.680 0.099 0.285 
Flat K (D) 43.79 1.443 0.336 0.193 0.016 
Steep K (D) 44.60 1.460 0.510 0.519 0.089 
Intended Flap Thickness 
(µm) 
94.53 5.069 0.018 N/A 0.495 
Optical Zone (mm) 6.05 0.343 0.211 0.880 0.712 
Pre-ablation Bed (µm) 458.66 30.187 0.227 N/A 0.939 
Actual Flap Thickness 
(µm) 
98.57 18.256 0.156 0.120 0.022 
Actual Ablation (µm) 59.17 27.192 0.143 0.739 0.379 
Remaining Stromal Bed 
(µm) 
407.66 71.624 0.537 N/A 0.184 
Preoperative Dryness Risk 
Assessment Consent 
N/A N/A 0.047 0.037 N/A 
Preoperative Visual 
Aberration Risk 
Assessment Consent 
N/A N/A N/A N/A 0.175 
 
Preoperative Risk Factors and Incidence of Dry Eyes 
Preoperative dry eye risk was assessed based on: contact lens use, subjective dry 
eye complaints with and without contact lenses, and Zone Quick test value less than 9.0 
mm. As previously indicated, the mean Zone Quick test was 20.54 ± 6.76 mm. 226 
participants (70.9%) wore contact lenses prior to surgery, and subjective dry eye 
complaints were noted with contact lens in 76 participants (23.8%) and without contact 
lenses in 17 participants (5.3%)(Table 6). Using these preoperative data points as well as 
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slit-lamp examination findings, the doctor had 29 (9.1%) of participants sign a consent 
warning that they were at risk for dry eye symptoms postoperatively due to their 
preoperative measurements. From the survey data, the mean OSDI score and new dry eye 
score for participants were, 10.66 ± 14.02 and 11.27 ± 12.79, respectively. 
Logistic regression ANOVA was performed on all of the preoperative factors 
gathered in Table 6 and the OSDI score and no significance was found (p = 0.190); 
however, there was an association found between the OSDI score and the following 
preoperative factors: those participants that consented to dry eye risk (p < 0.05), pupil 
size (p < 0.05), and actual flap thickness (p < 0.05). Logistic regression analysis was 
performed on the preoperative factors and the new dry eye score, which resulted in no 
significance (p = 0.444). An association was found between the new dry eye score and 
those participants that consented to having preoperative dry eye risk (p < 0.05). 
Additionally, the new dry eye score approached significance in showing an association 
between the score and the following risk factors: preoperative Zone Quick test value (p < 
0.1), gender (p <0.08), actual ablation (p <0.15), and actual flap (p <0 .16). 
The OSDI scoring system generalizes the score into 4 categories: score less than 
or equal to 10 is considered normal eyes, score of 10-20 is considered mild dry eyes, 
score of 20-30 points is considered moderate dry eyes, and score greater than 30 is 
considered severe dry eye. Table 7 shows that 69.3% of participants who did not consent 
to dry eye risk preoperatively had normal OSDI scores, and 58.6% of those who did 
consent to dry eye risk preoperatively had normal OSDI scores. Furthermore, only 8.2% 
of the total population (26 participants) had severe dry eyes, although 24 of those 
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participants with severe dry eye were from the group that was not identified for dry eye 
risk preoperatively. Chi-square test of this data did not show significant relationship (p > 
0.05) between the postoperative categories of dry eye symptom severity reported by 
OSDI scores and the consent to dry eye risk preoperatively (Figure 4). 
Table 7. Cross-tabulation between patients consenting preoperatively to dry eye risk and 
severity of symptoms postoperatively.  Participant OSDI dryness scores postoperatively were 
grouped into categories of normal (OSDI ≤10), mild (OSDI between 10-20), moderate (OSDI 20-
30), and severe (OSDI >30), and cross-tabulated with those participants who were identified as 
and consented to having preoperative dry eye risk. 
 OSDI Dryness Postoperatively  
Total Normal Mild Moderate Severe 
 
 
 
 
Dryness Risk 
Recognized 
Preoperatively 
 
 
No 
n 201 43 22 24 290 
Percent of 
participants 
without consent 
of dryness 
preoperatively 
69.3% 14.8% 7.6% 8.3% 100.0% 
 
 
Yes 
n 17 5 5 2 29 
Percent of 
participants 
with consent of 
dryness 
preoperatively 
58.6% 17.2% 17.2% 6.9% 100.0% 
 
Total 
n 218 48 27 26 319 
Percent of total 
participant 
population 
68.3% 15.0% 8.5% 8.2% 100.0% 
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Figure 4. Preoperative dry eye risk and severity of postoperative dry eye symptoms. The 
severity of postoperative dry eye symptoms based on the OSDI scores (normal: <10; mild: 10-20; 
moderate: 20-30; severe: >30) of participants who were and were not advised of their 
preoperative dry eye risk. (p = 0.320; Pearson Chi-Square) 
 
Preoperative Risk Factors and Incidence of Visual Aberrations 
Preoperative visual aberrations risk was assessed based on the following 
preoperative factors: spherical manifest refraction greater than -6.00, cylindrical manifest 
refraction greater than -2.00, pupil diameter greater than 7.0 mm. As previously 
indicated, the mean pupil diameter was 5.75 ± 0.89 mm, and 6.8% and 16.1% of eyes 
were above the preoperative risk for visual aberrations due to spherical and cylindrical 
manifest refraction measurements, respectively (Table 6). Using these preoperative data 
points and other evaluation findings, the doctor determined that 70 participants (21.9%) 
were at risk for visual aberrations and had the participants sign consent forms 
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acknowledging their preoperative risk. From the survey data, the mean visual aberration 
score was 21.73 ± 25.16. 
Logistic regression ANOVA was performed between the visual aberration score 
and the preoperative factors listed in Table 6 and found a significant association between 
them (p < 0.05). There was a significant association found between higher halo scores 
and greater cylindrical manifest refraction (p < 0.05), greater flat K value (p < 0.05), and 
greater actual flap thickness (p < 0.05). Additionally, the analysis approached 
significance in showing an association between the steep K value and visual aberration 
preoperative risk consent (p < 0.09 and p < 0.18, respectively). 
Participant postoperative visual aberration scores were assessed and patients were 
identified for either presence of visual aberrations (score greater than 10) or absence of 
visual aberrations (score less than or equal to 10). As seen in Table 8, 60.0 % of 
participants that preoperatively acknowledge having visual aberrations risk reported in 
their survey responses as having postoperative symptoms, while only 47.0 % of those 
participants not identified as having preoperative risk reported having symptoms in their 
survey responses. A chi-square test of the data showed that there is a significant 
relationship (p < 0.05; Fisher’s Exact Test) between those identified as having halo, 
starburst, or glare risk preoperatively and those patients that report visual aberration 
symptoms postoperatively (Figure 5). 
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Table 8. Cross-tabulation between patients consenting preoperatively to visual aberrations 
risk and incidence of symptoms postoperatively.  Participant visual aberration scores 
postoperatively were assessed for presence (score >10) or absence (score ≤10) of symptoms, 
and cross-tabulated with those participants who were identified as and consented to having 
preoperative visual aberrations risk. 
 Visual Aberrations 
Postoperatively 
 
Total 
No Yes 
 
Visual 
Aberrations 
Risk 
Consented 
Preoperatively 
 
 
No 
n 132 117 249 
Percent of participants 
without consent of visual 
aberrations preoperatively 
53.0% 47.0% 100.0% 
 
Yes 
n 28 42 70 
Percent of participants with 
consent of visual aberrations 
preoperatively 
40.0% 60.0% 100.0% 
 
Total 
n 160 159 319 
Percent of total participant 
population 
50.2% 49.8% 100.0% 
 
 
Figure 5. Preoperative visual aberrations risk and incidence of postoperative symptoms. 
Incidence of postoperative visual aberrations based on visual aberrations score (symptomatic 
>10; non-symptomatic ≤10) for patients who were and were not selected for consent 
documentation based on their preoperative risk for visual aberrations. (p < 0.05; Fisher’s Exact 
Test) 
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Symptom Comparison Between Years  
Participants were grouped by years since surgery and mean OSDI, dry eye, and 
visual aberration scores were calculated for each group (Table 9; Figure 6). ANOVA 
statistical testing was performed to determine if there were differences between the 
means of each group. No significant difference (p > 0.05) was found between groups for 
any of the scores tested; however, the OSDI score approached significance (p = 0.088). 
Table 9. Mean OSDI, dry eye, and visual aberration scores grouped by years since surgery. 
Participants grouped by years since surgery and the mean OSDI, dry eye, and visual aberration 
scores for each group of participants. Significance for ANOVA between-groups testing is shown 
under each score. 
 Years Since 
Surgery Groups 
Number of 
Participants in 
Group 
Mean Score 
Value 
Standard 
Deviation (±) 
 
 
OSDI Score 
(p = 0.088) 
1 89 10.51 14.70 
2 77 12.20 13.77 
3 79 8.48 10.36 
4 54 9.35 13.61 
5 20 17.50 22.24 
Total 319 10.66 14.02 
 
 
Dry Eye Score 
(p =0.134) 
1 89 11.05 13.02 
2 77 12.93 13.80 
3 79 9.51 9.61 
4 54 9.84 11.68 
5 20 16.65 19.28 
Total 319 11.27 12.80 
 
Visual 
Aberration 
Score 
(p =0.178) 
1 89 18.33 25.43 
2 77 23.60 29.18 
3 79 17.12 23.83 
4 54 18.12 25.20 
5 20 30.92 34.18 
Total 319 20.06 26.67 
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Figure 6. Mean OSDI, dry eye and visual aberration scores for participants whom are 1 to 5 
years post-surgery. Mean OSDI, dry eye, and visual aberration scores for patients who were 
grouped based on years since surgery. Error bars show standard deviation. No significance was 
found for any of the scores (p >0.05). 
 
Patient Satisfaction 
The last question of the survey asked participants whether they would repeat their 
decision to have surgery if they could do it all over again, and, if they selected no, to 
classify why they would not repeat their decision. Participants were able to select more 
than one reason for their dissatisfaction, if applicable. As shown in Table 10, 292 
participants (88.48%) would choose to repeat their decision to have surgery, and only 14 
participants (4.24%) would not repeat their decision to have surgery due to dry eyes or 
visual aberrations. 
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Table 10. Participant satisfaction with surgery. Participant satisfaction with surgery based on 
their willingness to repeat their original decision to have surgery, and if not, why they would not 
repeat their decision. 
 Would you repeat your decision to have surgery if you could do it all over again? 
 
Yes 
No, because of: 
Dry eyes Halos, 
starbursts, 
or glare 
Visual 
outcomes 
Another 
reason 
Total 
Number of 
Responses 
292 6 8 9 15 330 
Percent of 
Total 
Responses 
88.48% 1.82% 2.42% 2.73% 4.55% 100.00% 
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DISCUSSION 
Study Implementation 
Out of the 2926 patients originally identified as candidates only 319 (10.9%) 
qualified and participated in completing the questionnaire. Inability to reach participants 
(inaccurate or missing e-mail addresses) as well as less than 66.6% open rate accounted 
for much of the decrease from eligible patients to participants. The 319 survey 
participants allowed us to have 622 eyes available for study, but we were limited in our 
analysis because survey data did not individualize participants’ symptoms for each eye. 
Surveying patients’ symptoms for both eyes collectively made it difficult to analyze the 
effect of surgery type, LASIK versus surface ablation, on the long-term persistence of 
symptoms. Future studies should address whether LASEK patients continue to report less 
subjective symptoms than LASIK patients over long-term postoperative period, as has 
been noted previously during the follow-up period after CRLS (Herrmann et al., 2005).  
Additionally, many extended follow-up reports have focused on BCVA, regression, and 
refractive success after CRLS; however, our study did not consist of a clinical 
postoperative appointment, and therefore could not address those factors (Rajan et al. 
2004). 
 
Dry Eye Risk Factors 
Our data was able to show an association between the previously established 
OSDI score for assessing dry eye symptoms and several risk factors for dry eyes 
(Schiffman et al. 2000). We found a significant association between the OSDI score and 
	  43 
flap thickness in patients who are more than 1 year post-surgery, which supports similar 
relationships found identifying those factors as risk for postoperative dry eye during the 6 
months follow-up period (De Paiva et al., 2006). While those findings counter some 
associations made by Murakami & Manche (2012), our results support their findings that 
age was not shown to have a significant effect on postoperative dry eye symptoms. Our 
study also found a significant relationship between OSDI score for postoperative dryness 
and preoperative pupil size as a risk factor, which we believe has not been reported 
before. Future research should be done to address this finding and determine the 
reasoning behind this association. The OSDI score also had a significant association to 
the preoperative consent to dry eye risk that was performed per the Boston Laser practice 
standard. This assessment factor is based on many aspects of the preoperative evaluation 
including: contact lens use, dry eyes with contact lenses, Zone Quick tests ≤9mm, and 
individual slit-lamp findings by the doctor. This association between postoperative OSDI 
score and that evaluation could encompass all of those aspects, thus supporting current 
research claiming those factors as related to risk for developing persistent postoperative 
dry eyes (Raoof & Pineda, 2014). However, each patient evaluation is individualized and 
might not have all the aforementioned components of dry eyes, and therefore future 
studies must incorporate a more stringent classification of this consent to evaluate its 
usefulness of predicting postoperative dry eye risk. Additionally, the broad base of this 
preoperative risk factor and the limited patient population also likely contributed to the 
lack of statistical significance found between the OSDI score derived postoperative 
symptom severity and that preoperative factor. 
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 While the dry eye score created for the survey in this study did not achieve 
significance for association to preoperative variables, it did approach significance in 
relation to several variables: Zone Quick test, gender, actual ablation, and actual flap 
thickness. These findings could lend further support to those studies that have already 
identified them as risk factors (Raoof & Pineda, 2014). More research needs to be done to 
evaluate the effectiveness of this score on larger populations to determine its accuracy at 
showing dry eye symptoms, and to determine if the risk factors suggested have 
significant bearing on postoperative dry eye symptoms. 
 
Visual Aberration Risk Factors 
 This study found a significant association between the visual aberrations score 
and several preoperative risk factors: cylindrical manifest refraction, flat K value, and 
actual flap thickness. Previous studies have shown that increased ablation depth and level 
of myopic correction are related to increased risk for visual aberrations, while our data 
indicates that it might be the flap thickness and level of astigmatic correction that actually 
influence the incidence of visual aberrations (Bailey et al. 2003). These results could 
indicate new risk factors for development of halos, starbursts, and glare postoperatively, 
or could be due to the difference in time frame in which we attempted to associate 
symptoms with preoperative data. Additionally, the halo score approached significance 
with the preoperative steep K, which, combined with the significant associations of this 
score, suggests further studies are needed to examine the role of the keratometry 
measurements in preoperative risk for developing visual aberrations after CRLS. The 
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preoperative consent for visual aberration risk was shown to have significant association 
with those reporting starbursts, halos, or glare postoperatively using the visual aberration 
score. The preoperative consent for visual aberrations was based on spherical manifest 
refraction ≥ -6.00, cylindrical manifest refraction ≥ -2.00, and pupil diameter ≥ 7.0mm. 
While this significant association suggests that these factors might affect the risk for 
developing visual aberrations and thus contradict claims that pupil diameter, among other 
factors, do no affect visual aberration risk, it is difficult to determine exactly which of 
these factors affects long-term incidence of visual aberrations (Myung, Schallhorn, & 
Manche, 2013). Future investigations should be made with more stringent criteria for 
assigning this preoperative risk to enable researchers to determine what factors caused 
this association. 
 
Long-term Persistence of Dry Eye Symptoms and Visual Aberrations 
When evaluating the long-term incidence of both dry eye symptoms and visual 
aberrations symptoms by a comparison of the mean OSDI, dry eye, and visual aberration 
scores of the different years since surgery groups, our study data reached no significant 
difference between them. This result is not surprising given the relatively small 
population that completed the survey, and the fact that both the dry eye and visual 
aberration scores were new measures being tested for the first time in this study. The 
OSDI score means did approach significance (p= 0.088) in this between-group ANOVA 
testing, and thus further research should be done with larger sample populations and 
better supported measurements to assess this possibility. Another interpretation of these 
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results could revolve around the idea that previous studies have generally evaluated 
symptoms at most 6 months to 1-year postoperatively with a large proportion of dry eye 
and visual aberrations patients returning to preoperative baselines within 6-12 months in 
postoperative period, and only a small subset having chronic issues (Manche & Haw, 
2011; Raoof & Pineda, 2014). This could suggest that the lack of difference in means 
between patients that are 1-5 years post-surgery shows that patients who have symptoms 
persisting beyond one year will for the most part continue to experience them chronically 
throughout at least five years postoperatively. While this would be an unfortunate 
conclusion for those that continue to experience symptoms postoperatively, it shows the 
importance of continued and more stringent research into the long-term persistence of 
both dry eyes and visual aberrations and the risk factors for developing those conditions. 
 
Long-term Patient Satisfaction  
While 31.7% of participant are still experiencing some severity of dry eye 
symptoms and 49.8% of participants are experiencing visual aberrations after more than 1 
year postoperatively it does not seem to have affected patient satisfaction. As can be seen 
in our survey results: almost 90% of patients would still have decided to undergo their 
CRLS knowing their subjective results beforehand. Only 4.24% of all participants would 
not repeat their decision due to visual aberrations or dry eyes. Therefore, counter to some 
of the reported literature, we are led to believe that while these complications after CRLS 
are common, they do not significantly influence the subjective satisfaction of patients, 
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nor make them regret their decision to correct their vision through CRLS (Bailey et al. 
2003).  
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CONCLUSION 
Our study, one of the first to evaluate the long-term incidence of dry eyes and 
visual aberrations postoperatively, was able to introduce a number of suggested risk 
factors, supporting previous research, and therefore requiring further studies to confirm 
their roles. We found no reduction in the incidence of symptoms with longer follow up 
periods. While approximately 1/3 and 1/2 of participants experienced dry eyes and visual 
aberrations postoperatively, respectively, this did not affect patient satisfaction, as 
88.48% of participants would repeat their decision to have surgery given their individual 
outcomes. 
Limitations in our study design included: the lack of pre-surgery and 
postoperative interval questionnaires that would have been useful in comparing the 
progression of symptoms, clinical yearly follow-up appointments to address objective 
measurements of postoperative symptoms for comparison to pre-surgery data, survey 
questions individualized for right and left eye to allow for more robust data analysis on a 
per eye basis, and more thorough visual aberration questions in the survey that would 
address day and night time symptoms as well as addressing starburst, halos, and glare 
individually. Additionally, question 18 in the survey (Appendix A) did not include an 
option for “not currently experiencing visual aberration symptoms”, which made it hard 
to analyze the results of that question, and this might have affected statistical 
significance.  
Future studies should address the above-mentioned limitations as well as create 
more stringent pre- and postoperative testing criteria. This would include changing the 
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evaluation procedures to allow for more accurate pupil measurements, as the Colvard 
measurement can be more subjective based on the technician evaluating the prospective 
patient, and adding a greater variety of dry eye assessment methods, such as TBUT and 
corneal fluorescein stain clearance rate among others. 
 As one of the few studies to evaluate long-term dry eye and visual aberration 
complications after CRLS, we have identified a number of preoperative risk factors and 
suggested associations. Given the limitations of our methods we have identified a number 
of important avenues that would benefit from being explored in the future to clarify the 
significance of the results and aid in providing better consultation procedures for 
prospective CRLS patients.   
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APPENDIX A – PARTICIPANT QUESTIONNAIRE 
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